Wondering which popular ASX shares to buy, hold, or sell? Let's take a look at what analysts are saying about three popular options, courtesy of The Bull.
Here's what they are recommending to their clients:
Image source: Getty Images
BHP Group Ltd (ASX: BHP)
This mining giant's shares could be fully valued now following a strong run according to analysts at Morgans. As a result, the broker has put a hold rating on the Big Australian.
It thinks that investors should hold onto BHP's shares for the income but wait for a better entry point before increasing positions. The broker explains:
BHP remains a high quality diversified miner. The stock has performed well, with the price increasing from $34.16 on April 9, 2025 to trade at $51.39 on January 29, 2026. While capital discipline and dividend yield remain attractive, there isn't a compelling catalyst to add to portfolios at current levels, in our view. We suggest investors retain exposure for income and longer term portfolio balance, and wait for a potentially better entry point before increasing weight.
CSL Ltd (ASX: CSL)
Morgans thinks the risk-reward on offer with this biopharmaceutical giant's shares is attractive at current levels. As a result, it has named CSL shares as a buy.
The broker highlights that its current valuation is notably lower than long-term averages, which bodes well for buyers. It said:
This biopharmaceutical giant offers a stronger risk/reward profile after a period of share price underperformance. Plasma collections are rising, costs are normalising and earnings momentum is improving. Recovery at CSL Behring, a blood products division, remains on track and the influenza vaccination division Seqirus continues to provide defensive earnings. The current valuation sits well below long term averages despite fundamental improvement. This sets up an attractive long term capital growth story. Catalysts for a share price re-rating include an earnings recovery and margin expansion.
Endeavour Group Ltd (ASX: EDV)
The team at Capital Wealth is tipping this drinks giant as a hold this week.
It thinks that investors should keep their powder dry until it has released its updates in the coming months. It said:
Endeavour operates liquor outlets, hotels and gaming facilities. The company expects earnings before interest and tax (EBIT) of between $555 million and $566 million before significant items of $45 million in the first half of fiscal year 2026. Preliminary unaudited retail EBIT of between $323 million and $328 million reflects margin pressure from discounting that lifted Dan Murphy's and BWS sales by 0.7 per cent to $5.404 billion.
Hotel sales rose 4.4 per cent to $1.2 billion. Despite hotel strength and softer earnings, we continue to hold EDV pending its March and April updates as the company offers defensive attributes and could rebound on signs of successfully executing its strategy under new chief executive Jayne Hrdlicka.
